You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils

À propos des lignes directrices

Displaying Guidelines

361 articles

Recommended Criteria of a Pre-printed Order (PPO): Oral Chemotherapy Take-home Prescriptions

Document Status: Current
ID: GL-C50-21

Jul 2015

Recommendations for Prophylactic Cranial Irradiation and Consolidative Radiation for Patients with Small Cell Lung Cancer: Endorsement of the 2019 National Institute for Health and Care Excellence Guidance

Document Status: In-Review
ID: GL END 7-13-2
Version: 2

Nov 2019

Recommendations for the Delivery of Psychosocial Oncology Services in Ontario

Document Status: Current

Apr 2018

Recommendations for the Safe Use and Handling of Oral Anti-Cancer Drugs (OACDs) in Community Pharmacy: A Pan-Canadian Consensus Guideline

Document Status: Current
ID: GL-C50-30

Feb 2017

Recommendations for the Treatment of Patients with Clinical Stage III Non-Small Cell Lung Cancer: Endorsement of the 2019 National Institute for Health and Care Excellence Guidance and the 2018 Society for Immunotherapy of Cancer Guidance

Document Status: In-Review
ID: GL END 7-3
Version: 4

Apr 2020

Recommendations Report Microwave Ablation and Cryoablation

May 2021

Regional Models of Care for Systemic Treatment: Standards for the Organization and Delivery of Systemic Treatment

Document Status: Current
ID: GL 12-10
Version: 2

Jul 2019

Regional Therapies for Colorectal Cancer Liver Metastases

Document Status: Current
ID: GL 2-30a
Version: N/A

Mar 2020

Risk Reduction of Prostate Cancer with Drugs or Nutritional Supplements

Document Status: Education and Information
ID: 3-3

May 2012

Rituximab in Chronic Lymphocytic Leukemia

Document Status: Archived
ID: CED 15

Nov 2009

Rituximab in Lymphoma and Chronic Lymphocytic Leukemia: A Clinical Practice Guideline

Document Status: Archived
ID: 6-8
Version: 3

Mar 2015

Role of Adjuvant Treatment in Resected Pancreatic Ductal Adenocarcinoma

Document Status: Current
ID: GL 2-33
Version: 2

Updated

Jun 2025